Metraipolis › archive › dc_cd57c0c9dcbc

Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42630743
DOI
10.32604/or.2026.083193
License (as archived)
solo-consultazione
Archived
2026-10-16T15:39:52.451Z
SHA-256 of the archived text
306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3
Stable URL of this page
https://metraipolis.com/documento/dc_cd57c0c9dcbc

How to cite

Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743 — Europe PMC (en), https://europepmc.org/article/MED/42630743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd57c0c9dcbc (Metraipolis archive dc_cd57c0c9dcbc, sha256 306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3)
BibTeX
@misc{dccd57c0c9dcbc,
  title = {Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42630743},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd57c0c9dcbc; sha256 306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630743. Agents can read the archived copy with the MCP tool read_document.